Product
Peginterferon alfa-2a
2 clinical trials
3 indications
Indication
Hepatitis DIndication
Hepatitis BIndication
ChronicClinical trial
An Open-label, Dose-ranging, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Lonafarnib With and Without Ritonavir Boosting in Patients Chronically Infected With Delta Hepatitis (HDV) (LOWR-1)Status: Completed, Estimated PCD: 2015-09-01
Clinical trial
A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon Alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children With HBeAg Positive Chronic Hepatitis BStatus: Completed, Estimated PCD: 2015-07-09